Citation: | WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome, Nephrotic Syndrome, and Polycystic Kidney: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1069-1073. DOI: 10.12290/xhyxzz.2021-0678 |
[1] |
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4: 295-306. DOI: 10.1111/j.1538-7836.2006.01753.x
|
[2] |
Meroni PL, Raschi E, Testoni C, et al. Antiphospholipid antibodies and the endothelium[J]. Rheum Dis Clin North Am, 2001, 27: 587-602. DOI: 10.1016/S0889-857X(05)70222-2
|
[3] |
Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms[J]. J Clin Invest, 2000, 105: 1641-1649. DOI: 10.1172/JCI8931
|
[4] |
de Carvalho JF, Shoenfeld Y. Aneurysms in primary antiphospholipid syndrome: a case-based review[J]. Clin Rheumatol, 2021, 40: 3001-3006. DOI: 10.1007/s10067-020-05564-9
|
[5] |
Gracia-Tello B, Isenberg D. Kidney disease in primary anti-phospholipid antibody syndrome[J]. Rheumatology, 2017, 56: 1069-1080.
|
[6] |
Bienaimé F, Legendre C, Terzi F, et al. Antiphospholipid syndrome and kidney disease[J]. Kidney Int, 2017, 91: 34-44. DOI: 10.1016/j.kint.2016.06.026
|
[7] |
Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome[J]. J Am Soc Nephrol, 1999, 10: 507-518. DOI: 10.1681/ASN.V103507
|
[8] |
Ohara K, Kimura T, Karasawa T, et al. A large coronary aneurysm and its probable precursor lesions in a patient with autosomal dominant polycystic kidney disease: an implication for the process of aneurysmogenesis[J]. Pathol Int, 2012, 62: 758-762. DOI: 10.1111/pin.12007
|
[9] |
Neves JB, Rodrigues FB, Lopes JA. Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm: a systematic review[J]. Ren Fail, 2016, 38: 493-502. DOI: 10.3109/0886022X.2016.1144209
|
[10] |
Visciano B, Di Pietro RA, Rossano R, et al. Nephrotic syndrome and autosomal dominant polycystic kidney disease[J]. Clin Kidney J, 2012, 5: 508-511. DOI: 10.1093/ckj/sfs147
|
[11] |
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus[J]. Arthritis Rheumatol, 2019, 71: 1400-1412. DOI: 10.1002/art.40930
|
[1] | XU Kexin, LI Guozhuang, WU Zhihong, ZHANG Jianguo, DISCO(Deciphering Disorders Involving Scoliosis & Comorbidities) Study Group, WU Nan. Progress in Clinical Diagnosis and Management of Short Stature in Ehlers-Danlos Syndromes[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 163-170. DOI: 10.12290/xhyxzz.2024-0173 |
[2] | YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216 |
[3] | ZHANG Ning, YANG Chenhao, ZHOU Liangrui, SUN Xiaohong, LIU Xiaohong, KANG Lin, LI Ji, LI Hailong. Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 406-412. DOI: 10.12290/xhyxzz.2023-0476 |
[4] | ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180 |
[5] | Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555 |
[6] | Shuang ZHOU, Yue LI. Castleman Disease Variant of POEMS Syndrome: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(2): 202-206. DOI: 10.3969/j.issn.1674-9081.20170112 |
[7] | MAIMAITI Nu-rong-gu-li, Hua-bing ZHANG, Xiao-ping XING. Clinical and Genetic Analysis of a Uyghur Patient with Gitelman's Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(6): 427-431. DOI: 10.3969/j.issn.1674-9081.2015.06.006 |
[8] | Qing-jun WU, Zhang-han DAI, Wen ZHANG, Yong-zhe LI, Xin-ping TIAN, Xuan ZHANG, Yan ZHAO, Xiao-feng ZENG, Feng-chun ZHANG, Fu-lin TANG. Characteristics of Antisynthetase Syndrome with Anti-threonyl tRNA Synthetase Antibody[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(1): 26-30. DOI: 10.3969/j.issn.1674-9081.2013.01.006 |
[9] | Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004 |
[10] | Jing YANG, Bao-lai HUA, Shu-jie WANG, Chang-wen GE, Lian-kai FAN, Ye-hua HAN, Yong-qiang ZHAO. Fechtner Syndrome in a Chinese Family: A Case Report and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 171-175. |